Freepoint Capital Group logo

Freepoint Capital Group

Description

Freepoint Capital Group invests in healthcare innovation and technology solutions.

Investor Profile

Freepoint Capital Group has made 3 investments, with 3 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (67%)
  • Series D (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Medical
  • Biotechnology
  • Life Science
  • Oncology
  • Medical Device
  • Clinical Trials
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Freepoint Capital Group frequently co-invest with?

BP
North America, California, United States, San Francisco
Co-Investments: 1
CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
Hillhouse Investment
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Co-Investments: 1
Marshall Wace
Europe, England, United Kingdom, London
Co-Investments: 1
Abrdn
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 1
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 1
AbbVie Biotech Ventures
North America, Illinois, United States, North Chicago
Co-Investments: 1
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 1
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 1

What are some of recent deals done by Freepoint Capital Group?

Bright Uro

Aliso Viejo, California, United States

Bright Uro is an early-stage medical technology company.

Medical Device
Series AOct 31, 2024
Amount Raised: $32,000,000
Orasis Pharmaceuticals

Ponte Vedra, Florida, United States

Orasis Pharmaceuticals is an ophthalmic pharmaceutical company that develops eye drops for the treatment of presbyopia.

Clinical TrialsHealth CareMedicalPharmaceutical
Series DOct 8, 2024
Amount Raised: $68,000,000
Third Arc Bio

Boston, Massachusetts, United States

Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases.

BiotechnologyHealth CareLife ScienceMedicalOncology
Series AJul 23, 2024
Amount Raised: $165,000,000